Synklino

Synklino company information, Employees & Contact Information

Explore related pages

Related company profiles:

Synklino strives to provide rapid relief as well as to improve long-term survival for transplant recipients by providing fast and safe eradication of cytomegalovirus (CMV) infections. For transplant recipients, CMV disease causes suboptimal transplantation outcome, increased morbidity, prolonged hospitalization and increased mortality. Our drug candidate SYN002 efficiently eliminates both lytic as well as latently infected cells, and thereby potently inhibits viral replication and eradicates the virus - simply taking CMV out of the equation for the transplant recipient. SYN002 highly potently, efficiently and selectively eliminates CMV infected cells through a proven mechanism, allowing for both stand-alone and combination therapy.

Company Details

Employees
13
Founded
-
Address
Frederiksborggade, 1,2.th.,denmark
Phone
+45 20 12 16 56
Email
tn****@****ino.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Copenhagen, Capital Region of Denmark
Looking for a particular Synklino employee's phone or email?

Synklino Questions

News

Synklino raises €29.8M to trial cytomegalovirus drug - Labiotech.eu

Synklino raises €29.8M to trial cytomegalovirus drug Labiotech.eu

Top Synklino Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant